Sorrento Therapeutics, Inc. (SRNE)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: Jul 29, 2026
Sorrento Therapeutics Market Cap
Sorrento Therapeutics has a market cap or net worth of $271.86 thousand as of July 30, 2026. Its market cap has decreased by -80.00% in one year.
Market Cap
271.86K
Enterprise Value
n/a
Revenue
64.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since September 24, 2009, Sorrento Therapeutics's market cap has decreased from 112.54M to 271.86K, a decrease of -99.76%. That is a compound annual growth rate of -30.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 271.86K | -80.77% |
| Dec 31, 2025 | 1.41M | 420.00% |
| Dec 31, 2024 | 271.86K | -99.60% |
| Dec 29, 2023 | 67.15M | -83.68% |
| Dec 30, 2022 | 411.38M | -71.18% |
| Dec 31, 2021 | 1.43B | -18.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actavia Life Sciences | 385.91K |
| Innovation Pharmaceuticals | 317.26K |
| Altamira Therapeutics | 286.35K |
| Protagenic Therapeutics | 232.07K |
| Helix BioMedix | 229.20K |
| Ampio Pharmaceuticals | 207.88K |
| Carisma Therapeutics | 188.30K |
| CNBX Pharmaceuticals | 160.58K |